Deprescribing is a collaborative process, with the patient and/or their carer,to ensure the safe and effective withdrawal of medicines that are no longer appropriate, beneficial or wanted, guided by a person-centred approach and shared decision making.

deprescribing survey looking at pharmacist experiences. It is still live online until end of November 2022. Open to U.K. pharmacists who review psychotropic medication in people with a learning disability in either primary or secondary care.

Great opportunity for research teams to help us understand the links between #overprescribing, deprivation, ethnicity and inequalities and the impact this has on the health of the population @NIHRresearch @NHSEngland

Looking for a career change? Would you like to join the fantastic CQC Medicines Team as a medicines inspector? We have a vacancy for 18 months FTC/secondment in the South East. Pharmacists and Pharmacy Technicians please spread the word.

This is going to be an amazing #Deprescribing conference, I can't wait to see fantastic deprescribing world leaders together 😀 See the link below to submit your abstract See you there🤓 @DeprescribeNet @DeprescribeUS @DeprescribeAU @EDeprescribeN @Deprescribing @CentMedUseSafet

@adamtodd138 @BarbaraHanratty @Dr_AKingston @EDeprescribeN

**Job Opportunity 🔊** Are you a #pharmacist looking to work with people living in care homes delivering person-centred meds optimisation? Do you want to deliver great care as per @NHSEngland #Overprescribing report? Join our team - 8a part time vacancy

Medication reviews, shared decision-making and social prescribing highlighted as some of the ways to reduce overprescribing & depend critically on patient involvement. Check out ➡️ https://t.co/PVaTA6Vcs2

This and lots of other useful info in the Scottish Polypharmacy guidance - PDF is on link halfway down this page https://t.co/P55TYAtmGv #MedicinesOptimisation #Frailty #CareHomes

Deprescribing goes well beyond that initial shared decision to withdraw or stop medicines. Community-based pharmacists, who are well placed, play an important role in providing the necessary monitoring and post follow up with the view to ensure the success of the intervention.”

📢Delighted to share the 3rd paper during my PhD journey📢 Here, we present a systematic review of the evidence relating to associations between anticholinergics & adverse outcomes *specifically in older people with #frailty 📚📚 https://t.co/wAkU35bwIb #deprescribing #ACB

📢We have an exciting opportunity for a pharmacist with a passion in supporting colleagues in primary care to join our team as our new Pharmacy Integration Project Lead! Applications open until the 5th July: https://t.co/mHowORcIQ7

We are super excited to share that we have updated our website! Check it out and let us know what you think! @Deprescribing @DeprescribeUS @EDeprescribeN @DeprescribeNet @NDeprescribing https://t.co/sIYAEUtLNR

The organisations with the best experiences/outcomes of change are typically those with a culture of learning: where everyone can try new things, maybe fail & feel supported & respected. It needs psychological safety: https://t.co/3VhH4WbDe9 By @AdamMGrant #100RepeatTweets no.46

Very timely, we are updating the resources section on our platform 😀

Review article in @LancetLongevity by @RochonPaula & colleagues highlights the importance of applying a sex & gender lens when studying #polypharmacy, inappropriate prescribing & #deprescribing among older adults https://t.co/Wx363GRWmY @DeprescribeNet

Interviews GPs found they are confident in decisions to deprescribe when prompted by a trigger, such as a fall or adverse drug event, but less confident to attempt deprescribing in response to generalised concerns about polypharmacy. https://t.co/G9bWU51DCj

Analysis from large study of European & Israeli nursing home residents finds variation in #BZRA use across countries. Possible explanations incl. differences in national guidelines & prescribing practices. What else? https://t.co/y9Vf45GY4J @NDeprescribing @EDeprescribeN

1/n ATTENTION ALL DEPRESCRIBERS 📢 What are your reasons for joining a #deprescribing network and what do you hope to get out of it? Please let us know by filling in this brief survey 👇 https://t.co/RyntsSsIbv

Our updated fentanyl bulletin supports the review of the prescribing of immediate-release fentanyl in line with national guidance. #deprescribing View the bulletin here: https://t.co/kQgScXj1BE @keithridge1 @pcpa_org @elizbeech @EDeprescribeN @WePharmacists @CdsPcn @rpharms

Want to know more about #deprescribing of #antihypertensives in older adults? 🤔💊 Webinar recording now available: https://t.co/acD87hRqSb 👉🏽Presenter: @CochraneHTN author Dr. Emily Reeve @Reeve_Research #MedEd #hypertension #prescribing